R

ReNerve
RNV

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
A$14.39M
EV
A$9.63M
Shares Outstanding
143.88M
Beta
-
Industry
-

Wall Street View

Analyst Rating
-
Analyst Target Price
-
Number of Analysts
0
P/E 2026E
-
P/Revenue 2026E
-

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About ReNerve Limited

gainify

R

ReNerve Limited

RNV

ReNerve Limited, a medical device company, develops tissue-based products for peripheral nerve repair and replacement, and other related soft tissue surgical procedures. It develops NervAlign Nerve Cuff, a protective wrap used to protect repaired injured nerves; NervA...

Sector

Industry

CEO

Chick, Julian

Employees

IPO Date

Headquarters

157 Heidelberg Road, Northcote, Victoria, 3070, Australia

gainifypowered-by-sp
Socials
Send us an emailFollow us on XConnect with us on LinkedInFollow us on InstagramFollow us on ThreadsCheck us out on TrustpilotFollow us on YouTubeFind us on Google Maps

Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2025, S&P Global Market Intelligence. All rights reserved.

View Data Providers

NEWSLETTER

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

© 2025 Gainify. All rights reserved.